MARKET

DHTRF

DHTRF

DRI HEALTHCARE TRUST
OTCPK
9.39
NaN%
Closed 09:30 07/17 EDT
OPEN
--
PREV CLOSE
9.39
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
10.96
52 WEEK LOW
7.74
MARKET CAP
524.56M
P/E (TTM)
530.51
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DHTRF last week (0707-0711)?
Weekly Report · 3d ago
Weekly Report: what happened at DHTRF last week (0630-0704)?
Weekly Report · 07/07 12:17
Weekly Report: what happened at DHTRF last week (0623-0627)?
Weekly Report · 06/30 12:27
Weekly Report: what happened at DHTRF last week (0616-0620)?
Weekly Report · 06/23 12:15
Weekly Report: what happened at DHTRF last week (0609-0613)?
Weekly Report · 06/16 12:26
Weekly Report: what happened at DHTRF last week (0602-0606)?
Weekly Report · 06/09 12:28
Weekly Report: what happened at DHTRF last week (0526-0530)?
Weekly Report · 06/02 12:41
Weekly Report: what happened at DHTRF last week (0519-0523)?
Weekly Report · 05/26 12:40
More
About DHTRF
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.

Webull offers DRI Healthcare Trust stock information, including OTCPK: DHTRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DHTRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DHTRF stock methods without spending real money on the virtual paper trading platform.